Clindesse is a Vaginal Cream in the Human Prescription Drug category. It is labeled and distributed by Ther-rx Corporation. The primary component is Clindamycin Phosphate.
Product ID | 64011-124_a96a8d64-4abd-4ef0-a2db-558d973c4029 |
NDC | 64011-124 |
Product Type | Human Prescription Drug |
Proprietary Name | Clindesse |
Generic Name | Clindamycin Phosphate |
Dosage Form | Cream |
Route of Administration | VAGINAL |
Marketing Start Date | 2009-11-01 |
Marketing Category | NDA / NDA |
Application Number | NDA050793 |
Labeler Name | Ther-Rx Corporation |
Substance Name | CLINDAMYCIN PHOSPHATE |
Active Ingredient Strength | 20 mg/g |
Pharm Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2009-11-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050793 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-03-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | NDA |
Application Number | NDA050793 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2009-11-01 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
CLINDAMYCIN PHOSPHATE | 20 mg/g |
SPL SET ID: | dac31f82-b35e-49b9-aff9-f0101292f1be |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
45802-042 | Clindesse | Clindesse |
64011-124 | Clindesse | Clindesse |
0009-0302 | Cleocin Phosphate | clindamycin phosphate |
0009-0602 | Cleocin Phosphate | clindamycin phosphate |
0009-0728 | Cleocin Phosphate | clindamycin phosphate |
0009-0775 | Cleocin Phosphate | clindamycin phosphate |
0009-0870 | Cleocin Phosphate | clindamycin phosphate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CLINDESSE 78499863 3184560 Live/Registered |
PERRIGO PHARMA INTERNATIONAL DESIGNATEDACTIVITY COMPANY 2004-10-14 |